Table 5.
Association between serum potassium variability and risk of mortality in the subgroup.
| CVSP | N patients (%) | HR (95%, CI), All-cause mortality | HR (95%, CI), Cardiovascular mortality | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Unadjusted | p-value | Adjusted | p-value | Unadjusted | p-value | Adjusted | p-value | ||
| L-CVSP | 366 (74.2%) | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | ||||
| M-CVSP | 88 (17.8%) | 1.33 (0.81, 2.19) | 0.26 | 1.03 (0.62, 1.73) | 0.90 | 0.93 (0.39, 2.24) | 0.88 | 0.76 (0.30, 1.92) | 0.56 |
| H-CVSP | 39 (8.9%) | 2.36 (1.21, 4.60) | < 0.05 | 1.81 (0.91, 3.59) | 0.92 | 3.35 (1.39, 8.12) | < 0.01 | 2.69 (1.07, 6.78) | < 0.05 |
CVSP the coefficient of variation of serum potassium levels, HR hazard ratio.